Catabasis Pharmaceuticals Inc buy melinda
Start price
16.12.16
/
50%
€188.34
Target price
22.12.16
€216.48
Performance (%)
18.10%
End price
22.12.16
€222.43
Summary
This prediction ended on 22.12.16 with a price of €222.43. The prediction had a final performance of 18.10%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Catabasis Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
Comments by melinda for this prediction
In the thread Catabasis Pharmaceuticals Inc diskutieren
$ CATB & Daten innerhalb von Wochen zu erwarten
a +
Stopped prediction by melinda for Catabasis Pharmaceuticals Inc
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.84
27.10.20
27.10.20
€15.00
04.11.21
04.11.21
-20.00%
05.11.21
05.11.21
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€29.28
03.03.20
03.03.20
€33.00
27.10.20
27.10.20
-69.82%
27.10.20
27.10.20
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€188.33
04.10.17
04.10.17
€270.60
19.12.17
19.12.17
-53.02%
19.12.17
19.12.17
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€67.65
02.02.17
02.02.17
€108.24
10.03.17
10.03.17
68.84%
10.03.17
10.03.17
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€196.46
10.07.16
10.07.16
€270.60
04.08.16
04.08.16
39.97%
04.08.16
04.08.16